Does protocol heterogeneity in active surveillance influence clinical outcomes? Insights from a multicenter prostate cancer cohort

Korean journal of urology 2026 Open access

Read full text
Authors: Young Hwii Ko, Jae Hyun Ryu, Y Kim, Teak Jun Shin, Byung Hoon Kim
DOI: 10.4111/icu.20250460
Cited by: 2
References: 20

Abstract

PURPOSE: Active surveillance (AS) is recommended for men with low-risk prostate cancer, but institutional variability exists in eligibility criteria, confirmatory biopsy policies, and monitoring schedules. This study assessed whether protocol heterogeneity influences surveillance duration, treatment transition, and surgical pathology outcomes. MATERIALS AND METHODS: We retrospectively reviewed 232 men who initiated AS between 2014 and 2016 at three institutions with distinct protocols: Hospital A (Gleason Grade Group [GGG] 1-2, prostate-specific antigen [PSA]

Fields of Study & Subjects

Prostate Cancer Diagnosis and Treatment Prostate Cancer Treatment and Research Advanced Causal Inference Techniques

Publication details

Journal / source
Korean journal of urology
Publisher
XMLink
Volume
67
Issue
2
Pages
170–170
Publication date
1 January 2026
Language
EN